Observational Study on the Use of Ivermectin as an Outpatient Treatment Option for COVID-19

Status unconfirmed

Conditions studied: Covid19, COVID-19 Pneumonia, COVID-19 Respiratory Infection, COVID-19 Acute Bronchitis

In brief

Ivermectin is currently being utilized by a number of physicians in the local area. My objective will be to enroll these patients at the time of their evaluation for COVID-19 infection and to follow their progress through their recovery.

Key facts

Study ID

NCT05045937

Run by

Patrick Robinson

People needed

1000

Starts

2022-05-01

Expected to finish

2024-05-01

Last updated by the study team

2022-04-27

Who can join

Age: 12 and older, up to 110. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Between the ages of 12-110 years old
• Has a recently completed COVID test
• Symptomatic and seeking treatment
• Willingness to participate and have follow-up
• Able and willing to take medications and treatment suggestions from the physician
• Exclusion Criteria: Lack of symptoms, uncertain of COVID-19 status, outside of age limits for treatment
• No recent COVID test results
• Asymptomatic, even if COVID positive
• Outside of acceptable age range
• Meets criteria for hospital admission
• Unwilling to participate in trial study or have follow-up

Where it is running

• Patrick Robinson MD LLC — San Antonio, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.